Skip to main content

Table 1 Source of Antibodies

From: Proteomic characterization of non-small cell lung cancer in a comprehensive translational thoracic oncology database

Antibody

Vendor

c-Met

Zymed

p-Met 1003

Biosource

p-Met 1349

Biosource

p-Met 1365

Biosource

p-Met Triple

Biosource

HGF

R&D systems

Ronβ

Santa Crutz

p-Ronβ

Santa Crutz

Her3

Santa Crutz

EphA2

Santa Crutz

EphB4

Vasgen Therapeutics

Fibronectin

DAKO

β-catenin

Zymed

E-cadherin

Zymed

EzH2

Zymed

Snail

AVIVA Systems Biology

Vimentin

DAKO

Paxillin

Salgia Lab

GR

Novocastra

ERβ

Biogenex

PKCB-β1

Santa Crutz

PKCB-β2

GeneTex

  1. Antibodies were purchased from the listed manufacturers.